Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Engert

Showing results (51-60 of 379) with videos related to

Pageof 38
Sort By:
The New England Journal of Medicine|October 21, 2011
ABVD versus BEACOPP for Hodgkin's lymphomaPeter Borchmann, Volker Diehl, Andreas Engert
Nature Clinical Practice. Oncology|November 3, 2005
Axillary swelling and a reduced general condition in a middle-aged manBeate Klimm, Andreas Engert, Volker Diehl, et al.
Current Hematologic Malignancy Reports|April 29, 2010
Nodular lymphocyte-predominant Hodgkin's lymphomaLucia Nogovà, Volker Diehl, Andreas Engert, et al.
JAMA|December 26, 2008
Erythropoiesis-stimulating agents in the treatment of cancer-associated anemiaJulia Bohlius, Andreas Engert, Guido Schwarzer
Leukemia & Lymphoma|December 16, 2011
Adolescents with Hodgkin lymphoma: old children or young adults?Dennis A Eichenauer, Peter Borchmann, Andreas Engert
Leukemia & Lymphoma|June 1, 2016
Current and future immunotherapeutic approaches in Hodgkin lymphomaPaul J Bröckelmann, Peter Borchmann, Andreas Engert
Nature Reviews. Clinical Oncology|June 13, 2012
State of the art in the treatment of Hodgkin lymphomaPeter Borchmann, Dennis A Eichenauer, Andreas Engert
The Journal of Clinical Investigation|October 2, 2012
Hodgkin lymphomaRalf Küppers, Andreas Engert, Martin-Leo Hansmann
Current Opinion in Oncology|July 26, 2016
Current developments in the treatment of early-stage classical Hodgkin lymphomaSven Borchmann, Bastian von Tresckow, Andreas Engert
Hemasphere|January 17, 2020
Introducing the HemaSphere Controversies SeriesDennis A Eichenauer, Jan Cools, Andreas Engert
Pageof 38

Showing results (51-60 of 379) with videos related to

Sort By:
Pageof 38
The New England Journal of Medicine|October 21, 2011
ABVD versus BEACOPP for Hodgkin's lymphomaPeter Borchmann, Volker Diehl, Andreas Engert
Nature Clinical Practice. Oncology|November 3, 2005
Axillary swelling and a reduced general condition in a middle-aged manBeate Klimm, Andreas Engert, Volker Diehl, et al.
Current Hematologic Malignancy Reports|April 29, 2010
Nodular lymphocyte-predominant Hodgkin's lymphomaLucia Nogovà, Volker Diehl, Andreas Engert, et al.
JAMA|December 26, 2008
Erythropoiesis-stimulating agents in the treatment of cancer-associated anemiaJulia Bohlius, Andreas Engert, Guido Schwarzer
Leukemia & Lymphoma|December 16, 2011
Adolescents with Hodgkin lymphoma: old children or young adults?Dennis A Eichenauer, Peter Borchmann, Andreas Engert
Leukemia & Lymphoma|June 1, 2016
Current and future immunotherapeutic approaches in Hodgkin lymphomaPaul J Bröckelmann, Peter Borchmann, Andreas Engert
Nature Reviews. Clinical Oncology|June 13, 2012
State of the art in the treatment of Hodgkin lymphomaPeter Borchmann, Dennis A Eichenauer, Andreas Engert
The Journal of Clinical Investigation|October 2, 2012
Hodgkin lymphomaRalf Küppers, Andreas Engert, Martin-Leo Hansmann
Current Opinion in Oncology|July 26, 2016
Current developments in the treatment of early-stage classical Hodgkin lymphomaSven Borchmann, Bastian von Tresckow, Andreas Engert
Hemasphere|January 17, 2020
Introducing the HemaSphere Controversies SeriesDennis A Eichenauer, Jan Cools, Andreas Engert
Pageof 38